Sitryx Therapeutics
- Brad Robling
Brad Robling is the Vice President Corporate Business Development / Lilly New Ventures at Eli Lilly and Company. As such, he is focused on managing Eli Lilly’s venture capital investments globally.
Org chart
This person is not in the org chart
Teams
This person is not in any teams
